Litcius/Paper detail

Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy

Alice Romagnoli, Cristina Maracci, Mattia D’Agostino, Anna La Teana, Daniele Di Marino

2021Cancer Drug Resistance16 citationsDOIOpen Access PDF

Abstract

. This minireview explores the possibility of targeting mTOR and eIF4E proteins, thus impacting on translation initiation in ovarian cancer, describing the most promising experimental strategies and specific inhibitors that have been shown to have an effect on other kinds of cancers.

Topics & Concepts

EIF4EPI3K/AKT/mTOR pathwayOvarian cancerCancer researchEffectorTranslation (biology)BiologyCancerSignal transductionTargeted therapyMessenger RNACell biologyGeneGeneticsPI3K/AKT/mTOR signaling in cancerPolyamine Metabolism and ApplicationsBiochemical and Molecular Research
Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy | Litcius